Terms: = Liver cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Diagnosis
27 results:
1. Comparison of CT and gadoxetic acid-enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection.
Chen MF; Ho MC; Kao JH; Hwang RM; Deng SB; Yen KC; Liang PC; Wu CH
J Formos Med Assoc; 2024 Mar; 123(3):318-324. PubMed ID: 38044205
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic Performance of Modified Contrast-Enhanced Ultrasound liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline.
Zhang Y; Li Q; Li L; Hong Y; Qiang B; Yu Y; Guo R; Deng H; Han X; Zou X; Guo Z; Zhou J
Ultrasound Med Biol; 2024 Feb; 50(2):243-250. PubMed ID: 37985306
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Decision Support System for All Stages of Gastric Carcinogenesis in Real-Time Endoscopy: Model Establishment and Validation Study.
Gong EJ; Bang CS; Lee JJ; Jeong HM; Baik GH; Jeong JH; Dick S; Lee GH
J Med Internet Res; 2023 Oct; 25():e50448. PubMed ID: 37902818
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic Value of OPNI in Hepatocellular Carcinoma.
Zhou J; Yang D
Oncology; 2023; 101(8):481-490. PubMed ID: 37454651
[TBL] [Abstract] [Full Text] [Related]
5. Hyperbilirubinemia in hospitalized patients: Etiology and outcomes.
Kwon JY; Nietert PJ; Rockey DC
J Investig Med; 2023 Oct; 71(7):773-781. PubMed ID: 37386866
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS.
Luo M; Liu X; Yong J; Ou B; Xu X; Zhao X; Liang M; Zhao Z; Ruan J; Luo B
Eur Radiol; 2023 Jun; 33(6):4024-4033. PubMed ID: 36484835
[TBL] [Abstract] [Full Text] [Related]
7. Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents.
Degasperi E; Perbellini R; D'Ambrosio R; Uceda Renteria SC; Ceriotti F; Perego A; Orsini C; Borghi M; Iavarone M; Bruccoleri M; Rimondi A; De Silvestri A; Sangiovanni A; Lampertico P
Aliment Pharmacol Ther; 2022 Feb; 55(3):350-359. PubMed ID: 34738664
[TBL] [Abstract] [Full Text] [Related]
8. Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma.
Yang MY; Wu F; Fang F; Yang H; Zhang JF; Chen GD; Yang LY
BMC Cancer; 2021 Jul; 21(1):772. PubMed ID: 34217251
[TBL] [Abstract] [Full Text] [Related]
9. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract] [Full Text] [Related]
10. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
Yang L; Wei C; Li Y; He X; He M
Biomark Med; 2020 Oct; 14(15):1485-1500. PubMed ID: 33155836
[No Abstract] [Full Text] [Related]
11. Efficacy and Safety of Percutaneous Argon-Helium Cryoablation for Hepatocellular Carcinoma Abutting the Diaphragm.
Yang Y; Zhang Y; Wu Y; Chen J; Liang B; Chen Q; Wang Q; Lyu J; Li Y; Mu F; Du D
J Vasc Interv Radiol; 2020 Mar; 31(3):393-400.e1. PubMed ID: 31987705
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM
World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097
[TBL] [Abstract] [Full Text] [Related]
13. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood cancer Survivor Study.
Dietz AC; Seidel K; Leisenring WM; Mulrooney DA; Tersak JM; Glick RD; Burnweit CA; Green DM; Diller LR; Smith SA; Howell RM; Stovall M; Armstrong GT; Oeffinger KC; Robison LL; Termuhlen AM
Lancet Oncol; 2019 Oct; 20(10):1420-1431. PubMed ID: 31471158
[TBL] [Abstract] [Full Text] [Related]
14. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J
Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200
[TBL] [Abstract] [Full Text] [Related]
15. Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study.
Fanotto V; Fornaro L; Bordonaro R; Rosati G; Rimassa L; Di Donato S; Santini D; Tomasello G; Leone F; Silvestris N; Stragliotto S; Scartozzi M; Giampieri R; Nichetti F; Antonuzzo L; Cinieri S; Avallone A; Pellegrino A; Melisi D; Vasile E; Gerratana L; Aprile G
J Geriatr Oncol; 2019 Jul; 10(4):591-597. PubMed ID: 30551958
[TBL] [Abstract] [Full Text] [Related]
16. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.
Songthamwat M; Chamadol N; Khuntikeo N; Thinkhamrop J; Koonmee S; Chaichaya N; Bethony J; Thinkhamrop B
World J Surg Oncol; 2017 Sep; 15(1):176. PubMed ID: 28931405
[TBL] [Abstract] [Full Text] [Related]
17. liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.
Joo I; Lee JM; Lee DH; Ahn SJ; Lee ES; Han JK
J Magn Reson Imaging; 2017 Mar; 45(3):731-740. PubMed ID: 27474328
[TBL] [Abstract] [Full Text] [Related]
18. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.
Li N; Zhu Q; Yang C; Li F; Zhou Z; Lv Y; Sang J; Han Q; Liu Z
Tumour Biol; 2016 May; 37(5):6607-17. PubMed ID: 26643893
[TBL] [Abstract] [Full Text] [Related]
19. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma.
Smirne C; Grossi G; Pinato DJ; Burlone ME; Mauri FA; Januszewski A; Oldani A; Minisini R; Sharma R; Pirisi M
Dig Liver Dis; 2015 Jun; 47(6):488-94. PubMed ID: 25864774
[TBL] [Abstract] [Full Text] [Related]
[Next]